|
STARD7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
9.96319999999606E-05 |
| Normal-vs-Stage3 |
1.96789999962199E-07 |
| Normal-vs-Stage4 |
4.241600E-04 |
| Stage1-vs-Stage2 |
5.758200E-01 |
| Stage1-vs-Stage3 |
7.966800E-01 |
| Stage1-vs-Stage4 |
7.177400E-01 |
| Stage2-vs-Stage3 |
7.976400E-01 |
| Stage2-vs-Stage4 |
5.431400E-01 |
| Stage3-vs-Stage4 |
6.502400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.1689985625103E-11 |
| Normal-vs-Asian |
3.674000E-02 |
| Caucasian-vs-AfricanAmerican |
3.989600E-01 |
| Caucasian-vs-Asian |
9.659600E-01 |
| AfricanAmerican-vs-Asian |
8.166400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
6.76581013436817E-12 |
| Male-vs-Female |
1.181610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.50053319664312E-13 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.62581059726108E-12 |
| Normal-vs-Extreme_Obese |
6.514100E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.927600E-01 |
| Normal_Weight-vs-Obese |
2.484400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.557600E-01 |
| Extreme_Weight-vs-Obese |
1.441000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.439000E-01 |
| Obese-vs-Extreme_Obese |
5.905400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.35140000000223E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.02659999999355E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.858200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.479600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.592790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.376400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.352190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.907400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.63369318073592E-12 |
| Normal-VS-KIRP CIMP |
1.400540E-04 |
| Normal-VS-Unclassified PRCC |
2.20319999999496E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.335800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.221400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.371400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.864200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.415200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.703970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62558855265615E-12 |
| Normal-vs-N1 |
5.802000E-04 |
| Normal-vs-N2 |
1.21599952329632E-10 |
| N0-vs-N1 |
3.634000E-01 |
| N0-vs-N2 |
1.344200E-01 |
| N1-vs-N2 |
1.889170E-01 |
|
|
